Robert Niven

13.5k total citations · 1 hit paper
179 papers, 7.8k citations indexed

About

Robert Niven is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Robert Niven has authored 179 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Pulmonary and Respiratory Medicine, 104 papers in Physiology and 31 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Robert Niven's work include Asthma and respiratory diseases (101 papers), Respiratory and Cough-Related Research (59 papers) and Occupational exposure and asthma (29 papers). Robert Niven is often cited by papers focused on Asthma and respiratory diseases (101 papers), Respiratory and Cough-Related Research (59 papers) and Occupational exposure and asthma (29 papers). Robert Niven collaborates with scholars based in United Kingdom, United States and Canada. Robert Niven's co-authors include David W. Denning, B. Ronan O’Driscoll, Paul Bowyer, Andrew Menzies‐Gow, Cory M. Hogaboam, Liam G. Heaney, Christopher E. Brightling, Rekha Chaudhuri, Neil C. Thomson and Adel Mansur and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Robert Niven

167 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The link between fungi and severe asthma: a summary of the evidence

2006 649 citations David W. Denning, B. Ronan O’Driscoll et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Niven United Kingdom	46	4.7k	4.4k	1.3k	1.1k	811	179	7.8k
Angela Simpson United Kingdom	53	5.9k 1.2×	3.0k 0.7×	4.0k 3.1×	977 0.9×	376 0.5×	214	9.2k
Isabelle Pin France	48	4.7k 1.0×	3.9k 0.9×	1.3k 1.0×	1.5k 1.4×	174 0.2×	185	7.7k
Bénédicte Leynaert France	48	5.2k 1.1×	3.3k 0.8×	2.9k 2.3×	1.1k 1.0×	222 0.3×	136	8.3k
James E. Fish United States	40	5.0k 1.1×	4.4k 1.0×	1.2k 0.9×	298 0.3×	404 0.5×	109	7.0k
Klaus Bønnelykke Denmark	47	4.3k 0.9×	2.5k 0.6×	1.1k 0.9×	750 0.7×	450 0.6×	215	9.1k
Teal S. Hallstrand United States	41	3.7k 0.8×	4.8k 1.1×	510 0.4×	476 0.4×	260 0.3×	90	7.6k
B. Wallaert France	59	4.9k 1.0×	5.4k 1.2×	1.1k 0.9×	549 0.5×	700 0.9×	404	11.4k
Leif Bjermer Sweden	59	7.3k 1.5×	7.2k 1.7×	1.8k 1.4×	556 0.5×	240 0.3×	393	12.2k
Leonard B. Bacharier United States	55	8.1k 1.7×	6.2k 1.4×	1.6k 1.2×	513 0.5×	255 0.3×	233	11.4k
Guy Joos Belgium	61	5.1k 1.1×	5.1k 1.2×	943 0.7×	746 0.7×	291 0.4×	239	10.7k

Countries citing papers authored by Robert Niven

Since Specialization

Citations

This map shows the geographic impact of Robert Niven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Niven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Niven more than expected).

Fields of papers citing papers by Robert Niven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Niven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Niven. The network helps show where Robert Niven may publish in the future.

Co-authorship network of co-authors of Robert Niven

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Niven. A scholar is included among the top collaborators of Robert Niven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Niven. Robert Niven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Niven, Robert, et al.. (2019). European consensus meeting/statement on Bronchial Thermoplasty Who? Where? How?. Respiratory Medicine. 150. 161–164. 9 indexed citations

Jones, Kim, et al.. (2019). Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma. Journal of Asthma. 58(2). 141–150. 11 indexed citations

Patel, Dhiren F., Teresa Peiró, Amelia Shoemark, et al.. (2018). An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness. Science Translational Medicine. 10(455). 31 indexed citations

Heaney, Liam G., John Busby, Peter Bradding, et al.. (2018). Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma. American Journal of Respiratory and Critical Care Medicine. 199(4). 454–464. 99 indexed citations

Gómez-Larrauri, Ana, Simon Galloway, & Robert Niven. (2017). Achalasia with massive oesophageal dilation causing tracheomalacia and asthma symptoms. Respiratory Medicine Case Reports. 23. 80–82. 2 indexed citations

Niven, Robert, Dinesh Saralaya, Rekha Chaudhuri, et al.. (2016). Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study). BMJ Open. 6(8). e011857–e011857. 51 indexed citations

Djukanović, Ratko, Tim Harrison, Sebastian L. Johnston, et al.. (2014). The Effect of Inhaled IFN-β on Worsening of Asthma Symptoms Caused by Viral Infections. A Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 190(2). 145–154. 198 indexed citations

Fiterman, Jussara, et al.. (2013). Bronchial thermoplasty: long term effectiveness and safety in patients with severe persistent asthma. Journal of Allergy and Clinical Immunology. 1 indexed citations

Howell, Roger W., et al.. (2013). Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital. European Respiratory Journal. 42(Suppl 57). P977–P977. 1 indexed citations

10.

Laviolette, Michel, Ian Pavord, Neil C. Thomson, et al.. (2011). Safety of bronchial thermoplasty out to 5 years in patients with severe refractory asthma: Research in severe asthma (RISA) trial. European Respiratory Journal. 38(Suppl 55). 3422–3422. 1 indexed citations

11.

Niven, Robert & Amr Radwan. (2011). The APEX study: A retrospective review of responses of severe allergic asthma patients to omalizumab on continuous or non-continuous oral corticosteroids in UK clinical practice. European Respiratory Journal. 38(Suppl 55). p272–p272. 1 indexed citations

12.

Francis, Helen, Michelle L Hazell, Dave Singh, et al.. (2009). Prevalence of airflow obstruction in patients attending a rapid access chest pain clinic. Respiratory Medicine. 103(5). 736–742.

13.

Denning, David W., B. Ronan O’Driscoll, Georgina Powell, et al.. (2008). Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization. American Journal of Respiratory and Critical Care Medicine. 179(1). 11–18. 247 indexed citations

14.

Pavord, Ian, Gerard Cox, Neil C. Thomson, et al.. (2007). Safety and Efficacy of Bronchial Thermoplasty in Symptomatic, Severe Asthma. American Journal of Respiratory and Critical Care Medicine. 176(12). 1185–1191. 282 indexed citations

15.

Simpson, Angela, Sally John, Francine Jury, et al.. (2006). Endotoxin Exposure, CD14, and Allergic Disease. American Journal of Respiratory and Critical Care Medicine. 174(4). 386–392. 210 indexed citations

16.

Tavernier, G, Ivan Gee, A.F.R. Watson, et al.. (2006). IPEADAM study: Indoor endotoxin exposure, family status, and some housing characteristics in English children. Journal of Allergy and Clinical Immunology. 117(3). 656–662. 72 indexed citations

17.

Cox, Gerard, John F. Miller, Adalberto Sperb Rubin, et al.. (2006). Asthma Intervention Research (AIR) Trial Evaluating Bronchial Thermoplasty: Early Results. University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations

18.

Goldstein, Roger, Jeremy R. Bright, Susan Jones, & Robert Niven. (2006). Severe vocal cord dysfunction resistant to all current therapeutic interventions. Respiratory Medicine. 101(4). 857–858. 13 indexed citations

19.

Ayres, Jon G., Robert Niven, G. Ayre, Martin Blogg, & Helen Fox. (2003). Omalizumab reduces the rate of asthma deterioration-related incidents in patients with poorly controlled allergic asthma. Journal of Allergy and Clinical Immunology. 111(2). S202–S202. 3 indexed citations

20.

Niven, Robert & Christopher Pickering. (1996). Byssinosis: a review.. Thorax. 51(6). 632–637. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact